Experts recommend that CGT manufacturers proactively design a comprehensive market access strategy early in clinical development and commercial planning timelines, ideally more than three years prior ...

Unclear vision at product launch, misalignment of functions, no planned flexibility, slow response at key commercialization stages – sound familiar? Strategic planning is talked about a lot but is ...

Two hyperbolic cooling towers rise 495 feet over Exelon Corp.’s Byron Generating Station about 110 miles west of Chicago, Ill. The towers help cool the two Westinghouse pressurized water reactors that ...

Unified payer research planning is of top import. Historically, many companies have had ill-defined processes for planning market research activities across their product portfolio. Market research, ...

“The burdens of the NIH Access Plan Policy appear to be likely to create unacceptable commercial risks and uncertainty for potential private sector partners, which, in turn, will chill interest in ...

At the start of the year, the National Institutes of Health finalized a policy that will require anyone seeking to license certain NIH-owned patents to submit an “access plan” detailing how they plan ...

When people work with a fitness trainer, they expect a workout tailored to their abilities and goals. Similarly, when they work with an architect to design a new home, they expect the plans to reflect ...

The third report in this Center for American Progress series explores how states can pursue family planning options through Medicaid to expand access to contraception and other vital reproductive ...

Cell and gene therapies (CGTs) offer fresh hope to patients with serious and debilitating diseases, often where no other treatment options are available. Yet the process of getting to market and ...